Pasithea Therapeutics Corp.
KTTA
$0.57
-$0.03-4.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.06M | 8.70M | 8.71M | 7.11M | 6.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.79M | 17.89M | 16.69M | 13.86M | 13.76M |
| Operating Income | -19.79M | -17.89M | -16.69M | -13.86M | -13.76M |
| Income Before Tax | -21.29M | -19.73M | -20.43M | -13.49M | -13.46M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.29 | -19.73 | -20.43 | -13.49 | -13.46 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.29M | -19.73M | -20.43M | -13.49M | -13.46M |
| EBIT | -19.79M | -17.89M | -16.69M | -13.86M | -13.76M |
| EBITDA | -19.14M | -17.23M | -16.03M | -13.19M | -13.11M |
| EPS Basic | -1.48 | -1.98 | -3.47 | -5.21 | -7.68 |
| Normalized Basic EPS | -0.72 | -1.03 | -1.96 | -3.26 | -4.80 |
| EPS Diluted | -1.48 | -1.98 | -3.47 | -5.21 | -7.68 |
| Normalized Diluted EPS | -0.72 | -1.03 | -1.96 | -3.26 | -4.80 |
| Average Basic Shares Outstanding | 76.65M | 50.19M | 28.07M | 16.55M | 10.15M |
| Average Diluted Shares Outstanding | 76.65M | 50.19M | 28.07M | 16.55M | 10.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |